Cargando…
ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
Advanced stage non-small cell lung cancer and head and neck squamous cell carcinoma are both treated with DNA damaging agents including platinum-based compounds and radiation therapy. However, at least one quarter of all tumors are resistant or refractory to these genotoxic agents. Yet the agents ar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513219/ https://www.ncbi.nlm.nih.gov/pubmed/23226053 http://dx.doi.org/10.2147/PGPM.S20317 |